8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell …

T Lehrnbecher, D Averbuch, E Castagnola… - The Lancet …, 2021 - thelancet.com
Paediatric patients with cancer and those undergoing haematopoietic cell transplantation
are at high risk of bacterial infections. The 8th European Conference on Infections in …

The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic

D Reynolds, JP Burnham, CV Guillamet… - European …, 2022 - Eur Respiratory Soc
Antibiotic resistance is recognised as a global threat to human health by national healthcare
agencies, governments and medical societies, as well as the World Health Organization …

[HTML][HTML] Artificial intelligence to support clinical decision-making processes

C Garcia-Vidal, G Sanjuan, P Puerta-Alcalde… - …, 2019 - thelancet.com
Artificial intelligence (AI) proffers the ability of computer systems to perform human brain
tasks across various topics in all aspects of everyday life. Most clinical physicians are …

[HTML][HTML] Understanding and managing sepsis in patients with cancer in the era of antimicrobial resistance

C Gudiol, A Albasanz-Puig, G Cuervo… - Frontiers in …, 2021 - frontiersin.org
Sepsis is a frequent complication in immunosuppressed cancer patients and hematopoietic
stem cell transplant recipients that is associated with high morbidity and mortality rates. The …

Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock

M Chumbita, P Puerta-Alcalde, C Gudiol… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
We analyzed risk factors for mortality in febrile neutropenic patients with bloodstream
infections (BSI) presenting with septic shock and assessed the impact of empirical antibiotic …

[HTML][HTML] Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa

GL Daikos, CA da Cunha, GM Rossolini, GG Stone… - Antibiotics, 2021 - mdpi.com
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen that causes a range
of serious infections that are often challenging to treat, as this pathogen can express multiple …

Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia

Y Zhao, Q Lin, L Liu, R Ma, J Chen… - Clinical Infectious …, 2020 - academic.oup.com
Background Pseudomonas aeruginosa (PA) bloodstream infection (BSI) is a common
complication in patients with acute leukemia (AL), and the prevalence of antibiotic-resistant …

Pseudomonas aeruginosa: a clinical and genomics update

AC Pelegrin, M Palmieri, C Mirande… - FEMS Microbiology …, 2021 - academic.oup.com
Antimicrobial resistance (AMR) has become a global medical priority that needs urgent
resolution. Pseudomonas aeruginosa is a versatile, adaptable bacterial species with …

[HTML][HTML] Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders

C Xu, X Chen, G Zhu, H Yi, S Chen, Y Yu, E Jiang… - Journal of Infection, 2023 - Elsevier
Background Plasma cell-free DNA Next-Generation Sequencing has been used as a non-
invasive and comprehensive method for the etiological diagnosis of infectious diseases …

Does PTCY increase the risk of infections?

M Mikulska, C Bartalucci, AM Raiola, C Oltolini - Blood Reviews, 2023 - Elsevier
PTCY has been mainly used in haploidentical transplant (haploHSCT), but its use in
matched donors allowed better evaluation of infectious risk conferred separately by PTCY or …